Literature DB >> 33313679

The PDZ Domain Protein SYNJ2BP Regulates GRK-Dependent Sst2A Phosphorylation and Downstream MAPK Signaling.

Heather S Carr1, Jeffrey T Chang1, Jeffrey A Frost1.   

Abstract

The somatostatin receptor 2A (SST2) is a G-protein-coupled receptor (GPCR) that is expressed in neuroendocrine tissues within the gastrointestinal tract and brain, and is commonly overexpressed in many neuroendocrine tumors. Moreover, SST2 agonists are used clinically as the primary pharmacological treatment to suppress excess hormone secretion in a variety of neuroendocrine tumors. Despite its wide clinical use, mechanisms controlling the trafficking and signaling of SST2 are not fully understood. SST2 contains a C-terminal post-synaptic density 95, Drosophila discs large, zona-occludens 1 (PDZ) domain-binding motif that has been shown to interact with 3 different PDZ domain-containing proteins. However, the consequences of these interactions are not well understood, nor is it known whether additional PDZ domain proteins interact with SST2. Through unbiased screening we have identified 10 additional PDZ domain proteins that interact with SST2. We chose one of these, SYNJ2BP, for further study. We observed that SYNJ2BP interacted with SST2 in an agonist-dependent manner, and that this required the PDZ binding site of SST2. Importantly, overexpression of SYNJ2BP enhanced ligand-stimulated receptor internalization. Mechanistically, SYNJ2BP interacted with G-protein-coupled receptor kinase 2 (GRK2) and promoted GRK-dependent phosphorylation of the receptor after somatostatin stimulation. Interaction with GRK2 required the C-terminus of SYNJ2BP. Binding to SYNJ2BP did not affect the ability of SST2 to suppress 3',5'-cyclic adenosine 5'-monophosphate production, but was required for optimal agonist-stimulated extracellularly regulated kinase 1/2 activation. These data indicated that SYNJ2BP is an SST2-interacting protein that modulates agonist-stimulated receptor regulation and downstream signaling.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GRK2; MAPK; PDZ domain; SYNJ2BP; somatostatin receptor 2

Mesh:

Substances:

Year:  2021        PMID: 33313679      PMCID: PMC7799432          DOI: 10.1210/endocr/bqaa229

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  69 in total

1.  MAGI proteins can differentially regulate the signaling pathways of 5-HT2AR by enhancing receptor trafficking and PLC recruitment.

Authors:  Maha M Hammad; Henry A Dunn; Stephen S G Ferguson
Journal:  Cell Signal       Date:  2018-04-03       Impact factor: 4.315

Review 2.  Resistance to somatostatin analogs in acromegaly.

Authors:  Annamaria Colao; Renata S Auriemma; Gaetano Lombardi; Rosario Pivonello
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

3.  Identification of proteins interacting with the rat somatostatin receptor subtype 2.

Authors:  H J Kreienkamp; H Zitzer; D Richter
Journal:  J Physiol Paris       Date:  2000 May-Aug

4.  Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. Evidence for coupling of Ni to decreases in intracellular free calcium.

Authors:  B D Koch; L J Dorflinger; A Schonbrunn
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

5.  Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding.

Authors:  Q Liu; D A Dewi; W Liu; M S Bee; A Schonbrunn
Journal:  Mol Pharmacol       Date:  2007-11-02       Impact factor: 4.436

6.  Pertussis toxin blocks the somatostatin-induced inhibition of growth hormone release and adenosine 3',5'-monophosphate accumulation.

Authors:  M J Cronin; A D Rogol; G A Myers; E L Hewlett
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

7.  Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. II. An increase in potassium conductance initiates somatostatin-induced inhibition of prolactin secretion.

Authors:  B D Koch; A Schonbrunn
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

8.  Single-Cell RNA Sequencing Reveals Novel Markers of Male Pituitary Stem Cells and Hormone-Producing Cell Types.

Authors:  Leonard Y M Cheung; Akima S George; Stacey R McGee; Alexandre Z Daly; Michelle L Brinkmeier; Buffy S Ellsworth; Sally A Camper
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

Review 9.  Illuminating somatostatin analog action at neuroendocrine tumor receptors.

Authors:  Jean Claude Reubi; Agnes Schonbrunn
Journal:  Trends Pharmacol Sci       Date:  2013-10-31       Impact factor: 14.819

10.  Subcellular sorting of the G-protein coupled mouse somatostatin receptor 5 by a network of PDZ-domain containing proteins.

Authors:  Carola Bauch; Judith Koliwer; Friedrich Buck; Hans-Hinrich Hönck; Hans-Jürgen Kreienkamp
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.